Skip to content
About LineaRx
Leadership Team
Investor Info
LinearDNA Platform
Biotherapeutic Applications
News
Resources
Let’s Connect
About
About LineaRx
Leadership Team
Investor Info
Platform
Applications
News
Resources
Let’s Connect
APDN to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
May 21, 2020
Read More
email
APDN to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5
April 14, 2020
Read More
email
APDN to Hold Investment Community Meetings During the JP Morgan 38th Annual Healthcare Conference and Present at the Biotech Showcase 2020
January 10, 2020
Read More
email
Recent Press Releases
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea™ RNAP, Progresses Towards GMP Linea™ IVT Production Start
Applied DNA to Showcase Linea™ DNA and Linea™ IVT Platforms
Applied DNA Announces Joint Development Agreement to Integrate Linea™ IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
APDN Announces Receipt of Linea™ DNA Follow-On Order for Cancer Diagnostic Application
Applied DNA Extends Application of Linea™ IVT Platform to saRNA (self-amplifying mRNA)
Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea™ DNA Platform
APDN Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
APDN Advances Commercialization of Linea™ IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
LineaRx to Participate in Upcoming mRNA Industry Conferences
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
